All The Microbiologist articles in Web Issue – Page 195
-
NewsContagious omicron strain replicates early in infection
New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.
-
NewsValneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
-
NewsAntibiotics can help some bacteria survive for longer
Scientists have found a surprising effect of some antibiotics on certain bacteria – that the drugs can sometimes benefit bacteria, helping them live longer.
-
NewsResearchers pioneer safe chemotherapy methods for treating bacterial infections
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. A new class of antibiotics is now being developed by researchers at ...
-
OpinionMuch ado about microbes
A group of leading scientists has recently reviewed the benefits and risks of Gain of Function research and issued new consensus recommendations - Simon Wain-Hobson examines the report exclusively for The Microbiologist.
-
NewsAntiviral drug linked to SARS-CoV-2 mutations
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
-
NewsResearchers reveal how microbes return after a wildfire
A study suggests that dispersal - through air or rain, for example - plays a major role in microbial succession after a destructive fire.
-
NewsClimate warming could impact forest resilience by disrupting fungal networks
Researchers find that warming trends will likely result in major disturbances of networks of fungi, potentially harming forest resilience.
-
NewsNew research reveals gut microbiota link to colitis - and therapetic strategies
Researchers have revealed a new and critical role of Axin1 in regulating intestinal epithelial development and microbial homeostasis.
-
FeaturesBiodeterioration and bioconservation of Mayan historical monuments: two sides of a coin
How understanding the microbiology of ancient sites is allowing researchers to preserve cultural heritage.
-
-
NewsNanoparticle vaccine candidate shows promise against emerging tick-borne virus
Researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that has no prevention, treatment or cure.
-
NewsHops compound reduces abundance of gut microbe associated with metabolic syndrome
Researchers have shown in a mouse model and lab cultures that a compound derived from hops reduces the abundance of a gut bacterium associated with metabolic syndrome.
-
NewsDiscovery in mosquitoes could lead to new strategy against dengue fever
Researchers have discovered that a protein in the mosquito Aedes aegypti , Argonaute 2, has a key role - via several biological mechanisms - in keeping mosquitoes healthy and active despite the presence of viral infections like dengue and Zika.
-
CareersIgnoring the rise of anti-science could usher back once-deadly diseases
As a wave of anti-science sentiment sweeps the globe, scientists need to speak up, says paediatric vaccine scientist Dr Peter Hotez in an interview with The Microbiologist as he launches his new book.
-
NewsScientists develop mRNA vaccine against Lyme disease-causing bacteria
An experimental mRNA vaccine provides protection in preclinical animal models against infection from Borrelia burgdorferi, the bacterium that causes Lyme disease, according to new research.
-
NewsClinical trial of HIV vaccine begins in United States and South Africa
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people. Source: NIAID Transmission electron micrograph ...
-
NewsUnzipping mRNA rallies plant cells to fight infection
Scientists studying a plant called Arabidopsis thaliana have discovered short snippets of folded RNA that are unzipped in the presence of a pathogen to allow plant cells to make defense proteins to fight infection.
-
NewsResearch on bee virus origins uncovers buzz-worthy breakthrough
A study of deformed wing virus, a key driver in declines among European honey bee populations, show that one of the most common strains, DWV-A, originated in Asia and not Europe, as previously suggested.
-
NewsNew NTU Singapore research centre on lung health
To better tackle respiratory diseases in Singapore, Nanyang Technological University, Singapore (NTU Singapore) has set up a new research centre designed to address lung diseases in an Asian context.